(Q46841533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Kwan Soo Byun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Oh Sang Kwon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ju Hyun Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Hyung Joon Yim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Yun Jung Chang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jin Yong Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jong Eun Yeon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jong Jae Park

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jae Seon Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Chang Hong Lee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1838-1842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Durability of serologic response after lamivudine treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Determinants for sustained HBeAg response to lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03952.X

10.1111/J.1440-1746.2005.03952.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16336441%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference